Last week was a holiday-shortened week, but didn't lack for fireworks. Greece and the leaders of the eurozone finally reached an agreement that will funnel new bailout funds to the heavily indebted nation and allow it to avoid a messy default -- at least for now. But if that should have given the market a nice shot in the arm, optimism was tempered as the continued drumbeat of weak economic performance throughout the rest of the eurozone continued. The major U.S. indexes finished in the black for the week, but the gains were very moderate.
The Dow Jones Industrial Average
Top 3 Performing Sectors
|
|
|
---|---|---|
Energy | 1.9% | 8.1% |
Information technology | 0.8% | 7.0% |
Telecom services | 0.8% | 4.4% |
Source: S&P Capital IQ. Weekly price change is Feb. 17 to Feb. 24. Monthly price change is Jan. 31 to Feb. 24.
Biopharma company VIVUS
Corcept Therapeutics
Top 3 Performing Russell 3000 Companies
|
|
---|---|
VIVUS | 84.6% |
Corcept | 43.5% |
Sourcefire | 27.6% |
Source: S&P Capital IQ. Weekly price change is Feb. 17 to Feb. 24. Only includes companies with a market cap of $250 million or higher.
Believe it or not, you didn't need to have a novel drug approved -- or near approval -- by the FDA to register big gains this week. Sears Holdings
Meanwhile, 3-D printing expert 3D Systems
That's it for this week's top performers recap. If you're looking for some ideas for strong outperformers for the rest of year, The Motley Fool has created a brand-new free report titled "The Motley Fool's Top Stock for 2012." In it, my fellow Fools reveal a top pick that's poised for explosive growth ahead. Get instant access by clicking here -- it's free.